期刊
ANNALS OF HEMATOLOGY
卷 97, 期 1, 页码 17-29出版社
SPRINGER
DOI: 10.1007/s00277-017-3151-2
关键词
Lymphoma; Lymphoma, follicular; Lymphoma, non-Hodgkin; Lymphoma, large B cell; Diffuse; Diffuse large cell lymphoma; Epigenetic; Prognosis, cell neoplastic transformation; Cell transformation, neoplastic; Genetic transformation
类别
Follicular Lymphoma (FL) is the second most common type of non-Hodgkin lymphoma and is considered to be the prototype of indolent lymphomas. Histologic transformation into an aggressive lymphoma, which is expected to occur at a rate of 2 to 3% each year, is associated with rapid progression, treatment resistance, and poor prognosis. Recent modifications to the physiopathologic mechanism of transformed follicular lymphoma (t-FL) have been proposed, including genetic and epigenetic mechanisms as well as a role for the microenvironment. Although t-FL is considered a devastating complication, as it is associated with treatment-refractory disease and a dismal outcome, recent data in the rituximab era have suggested that not only is the prognosis less severe than reported in the previous literature but the risk of transformation is also lower. Thus, this study aimed to review the most recent research on t-FL in an attempt to better understand the clinical meaning of transformation from FL to diffuse large B cell lymphoma (DLBCL) and the impact of current treatment strategies on the curability of this intriguing subentity of lymphoma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据